TWO SIGMA ADVISERS, LP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 108 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$423,000
-33.0%
8,000
-22.3%
0.00%
-50.0%
Q2 2020$631,000
-9.3%
10,300
-16.3%
0.00%
-33.3%
Q1 2020$696,000
-3.7%
12,300
-3.1%
0.00%
+50.0%
Q4 2019$723,000
+75.5%
12,700
+64.9%
0.00%
+100.0%
Q3 2019$412,000
-24.1%
7,700
-15.4%
0.00%0.0%
Q2 2019$543,000
+6.3%
9,100
+11.0%
0.00%0.0%
Q1 2019$511,000
-31.4%
8,200
-33.3%
0.00%
-50.0%
Q4 2018$745,000
-9.0%
12,300
-12.1%
0.00%0.0%
Q3 2018$819,000
+41.5%
14,000
+8.5%
0.00%0.0%
Q2 2018$579,000
-15.2%
12,900
-16.2%
0.00%0.0%
Q1 2018$683,000
+2.4%
15,4000.0%0.00%0.0%
Q4 2017$667,000
-10.3%
15,400
-3.8%
0.00%0.0%
Q3 2017$744,000
-16.0%
16,000
-10.6%
0.00%
-33.3%
Q2 2017$886,000
-9.7%
17,9000.0%0.00%0.0%
Q1 2017$981,000
-20.3%
17,900
-19.0%
0.00%
-40.0%
Q4 2016$1,231,000
+19.7%
22,100
-1.8%
0.01%
+25.0%
Q3 2016$1,028,000
-2.1%
22,500
-14.4%
0.00%
-20.0%
Q2 2016$1,050,000
+1.5%
26,300
-11.4%
0.01%
-16.7%
Q1 2016$1,034,000
-0.6%
29,700
+22.7%
0.01%0.0%
Q4 2015$1,040,000
-2.8%
24,200
-1.2%
0.01%
-14.3%
Q3 2015$1,070,000
-13.6%
24,500
+2.1%
0.01%
-30.0%
Q2 2015$1,238,000
+54.9%
24,000
+17.6%
0.01%
+66.7%
Q1 2015$799,000
-9.6%
20,400
-10.9%
0.01%
-14.3%
Q4 2014$884,000
+242.6%
22,900
+213.7%
0.01%
+250.0%
Q3 2014$258,0007,3000.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders